Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Melanoma (Skin) Clinical Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/6/2009
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Status: Enrolling
Updated: 10/16/2007
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Skin Cancer Clinical Trial
Spectral Diagnosis of Cutaneous Malignancy
Status: Enrolling
Updated: 9/16/2013
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 9/19/2012
mi
from
Harvey, IL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
Status: Enrolling, Phase IV
Updated: 7/28/2009
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Atlanta, GA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Easton, PA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Akron, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Flemington, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Normal, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Status: Enrolling
Updated: 6/24/2013
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study to Compare the Effect of Ipilimumab Retreatment With Chemotherapy in Advanced Melanoma
Status: Enrolling
Updated: 10/15/2013
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Melanoma Clinical Trial
Study to Compare the Effect of Ipilimumab Retreatment With Chemotherapy in Advanced Melanoma
Status: Enrolling
Updated: 10/15/2013
mi
from
Lebanon, NH
Click here to add this to my saved trials
Melanoma Clinical Trial
Study to Compare the Effect of Ipilimumab Retreatment With Chemotherapy in Advanced Melanoma
Status: Enrolling
Updated: 10/15/2013
mi
from
Lexington, KY
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Aurora, CO
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Beverly HIlls, CA
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Houston, TX
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Manchester, MO
Click here to add this to my saved trials
Locally Advanced or Metastatic NRAS Mutant Melanoma Clinical Trial
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
Status: Enrolling, Phase I, II
Updated: 11/20/2015
mi
from
Nashville, TN
Click here to add this to my saved trials
Locally Advanced or Metastatic NRAS Mutant Melanoma Clinical Trial
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
Status: Enrolling, Phase I, II
Updated: 11/20/2015
mi
from
San Francisco, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of BMS-936558 vs. Dacarbazine in Untreated, Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/19/2013
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
Status: Enrolling, Phase II
Updated: 7/10/2015
mi
from
Aurora, CO
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Status: Enrolling
Updated: 3/28/2013
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Status: Enrolling
Updated: 3/28/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Status: Enrolling
Updated: 3/28/2013
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Status: Enrolling
Updated: 3/11/2013
mi
from
Nashville, TN
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Orlando, FL
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Houston, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Iowa City, IA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Niles, IL
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Seattle, WA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Southfield, MI
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
St. Louis, MO
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Washington DC,
Click here to add this to my saved trials
Melanoma Clinical Trial
Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
Status: Enrolling
Updated: 3/18/2014
mi
from
Portland, OR
Click here to add this to my saved trials
Melanoma Clinical Trial
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
Status: Enrolling
Updated: 6/25/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma Clinical Trial
Trametinib With GSK2141795 in BRAF Wild-type Melanoma
Status: Enrolling, Phase II
Updated: 10/25/2013
mi
from
San Francisco, CA
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 11/5/2015
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
Status: Enrolling, Phase I
Updated: 12/6/2013
mi
from
Rochester, MN
Click here to add this to my saved trials
Intraocular Melanoma Clinical Trial
Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling
Updated: 9/5/2012
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Lebanon, NH
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
Status: Enrolling
Updated: 5/29/2013
mi
from
Houston, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
Status: Enrolling
Updated: 11/5/2015
mi
from
Stanford, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma
Status: Enrolling, Phase I
Updated: 9/6/2013
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 6/9/2015
mi
from
San Francisco, CA
Click here to add this to my saved trials
Unresectable or Metastatic Melanoma Clinical Trial
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Status: Enrolling, Phase III
Updated: 2/26/2014
mi
from
New York, NY
Click here to add this to my saved trials
Unresectable or Metastatic Melanoma Clinical Trial
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Status: Enrolling, Phase III
Updated: 2/26/2014
mi
from
Orlando, FL
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Iowa City, IA
Click here to add this to my saved trials
Melanoma Clinical Trial
A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
Status: Enrolling, Phase I, II
Updated: 12/30/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Melanoma Clinical Trial
BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation
Status: Enrolling, Phase II
Updated: 3/25/2015
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Melanoma Clinical Trial
LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
Status: Enrolling, Phase II
Updated: 7/29/2014
mi
from
Tampa, FL
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/28/2014
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Melanoma Clinical Trial
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
Status: Enrolling, Phase III
Updated: 11/20/2015
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Status: Enrolling
Updated: 12/28/2015
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Status: Enrolling
Updated: 12/28/2015
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Chicago, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Cleveland, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Green Bay, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Hershey, PA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Aiea, HI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Atlanta, GA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Billings, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Casper, WY
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Elmhurst, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Independence, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Kalispell, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Kansas City, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Lewistown, PA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Little Rock, AR
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Maplewood, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Salina, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Shakopee, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Sioux City, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Sioux City, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
State College, PA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Wausau, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
New York, NY
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Knoxville, TN
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Melanoma Clinical Trial
Trial of pIL-12/MK-3475 in Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 7/16/2015
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 11/3/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Uveal Melanoma Clinical Trial
Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Status: Enrolling, Phase II
Updated: 8/6/2015
mi
from
New York, NY
Click here to add this to my saved trials
Malignant Melanoma, Metastatic Clinical Trial
MRI/PET Imaging to Assess Response to Pembrolizumab in Metastatic Melanoma
Status: Enrolling, Phase
Updated: 10/28/2015
mi
from
New York, NY
Click here to add this to my saved trials
Malignant Skin Neoplasm Clinical Trial
Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery
Status: Enrolling
Updated: 9/29/2015
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1b Safety Study of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Status: Enrolling, Phase I
Updated: 12/10/2015
mi
from
New Haven, CT
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 66